Trintellix (vortioxetine) is a prescription medicine that affects chemicals in the brain that may be unbalanced.
Trintellix is an antidepressant that is used to treat major depressive disorder in adults.
Trintellix is supplied as an immediate-release tablet in 5mg, 10mg, and 20mg strengths.
In May 2016 Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck announced that Brintellix will be marketed in the United States under the new name Trintellix effective June 2016. The change comes after receiving reports of name confusion in the marketplace between Brintellix and the anti-blood clotting therapy Brilinta (ticagrelor). The formulation, indication, dosage forms and strengths of Trintellix remain the same as Brintellix.
